Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Tripling my carbs --> 5 fewer hours in-range per day, 64% more insulin (!), & more lessons learned.
Who is “closing the loop,” and how fast are they moving?
Adam Brown leads expert panel discussion at The diaTribe Foundation’s first-ever digital health gathering at ADA 2016.
What does A1c miss and what can we do about it?
What to do if you have United insurance.
Sept. 28 was a big day for diabetes tech approvals in the US – a big step in bringing the latest and greatest tech to people with diabetes!
Key lessons learned from one woman’s ongoing battle with adrenal insufficiency, and the unexpected role of diabetes technology.
Launches in the next 12-18 months. What we’re excited about…!
A run-down on insurance and other payment assistance programs for medical services and prescription medicines
Views on FDA regulation, pipeline updates, and first vs. next-generation systems.
A standing ovation for Dr. Margaret Powers at ADA last month r Dr. Margaret Powers at ADA last month.
Free for patients! Initially available in Austria and Germany, and soon in the US.
Dexcom’s new insertion, Android G5, touchscreen receiver; Medtronic’s Android MiniMed Connect, Hypo Prediction App, 670G, and Guardian Connect.
Public workshop scheduled at FDA for August 29, 2016. Get involved!
What to look for when comparing plans in the insurance marketplace
Details on monthly test strip subscription plan and our first impressions.
The Annual TCOYD/The diaTribe Foundation Forum Celebrates its 10 th Anniversary in New Orleans
Adds waterproof, color screen, and remote meter bolus. Will it speed FDA review of the 670G hybrid closed loop?
Details for Dexcom July 21 Advisory Panel meeting posted. How to submit a written statement to the FDA or attend in person.
The diaTribe Foundation’s 2016 gathering shares need for earlier treatment, data integration, prevention, amplifying patient voices, and reducing stigma.